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The problem of demonstrating antibodies in allergic eczematous contact-type
sensitization has always been of great interest to the dermatologist. For it is
perhaps in eczematous sensitization more than in any other form in human
beings that the clinical events often present the most beautiful demonstration
of the cardinal characteristics of allergic sensitization. Here one can observe in
clear cut fashion such immunologic phenomena as the incubation period, the
spontaneous flare-up, the local differences in sensitivity, the corning and waning
of sensitivity, as well as many other of the well known characteristic allergic
phenomena.
Despite this great interest in allergic eczematous sensitization in man and
despite the use of many different technics, it has hitherto not been possible to
demonstrate the presence of antibodies, either through passive transfer of the
sensitization from one human being to another, or in any other fashion. How-
ever, in the last two decades an increasing amount of evidence has accumulated
from work in experimental animals and to a smaller extent in human beings
which would indicate that the lymphocytes, monocytes and plasma cells are,
if not the actual producers, then at least the carriers of the long-sought antibodies
in the eczematous form of allergy.
While this is not the proper place for a review of the entire literature on this
subject we wish to mention here a few of the pieces of evidence which appear to
us to be particularly pertinent.
Landsteiner and Chase (1) were able to passively transfer tuberculin-type and contact-
type allergic sensitivity in guinea pigs by means of suspensions of white cells from peritoneal
exudates of sensitized guinea pigs. The degree of sensitivity transferred appeared to depend
on the quantity of white cells used. It was also demonstrated that mononuclear cells pre-
dominated in these exudates and that transfer could be achieved as well with cells from the
spleen and lymph glands.
Haxthausen (2) confirmed these results and was able to demonstrate passive transfer in
experimental animals also with an almost exclusively lymphocytic suspension prepared
from the thymus in guinea pigs. However, he could not passively transfer eczematous sen-
sitivity in human volunteers by means of citrated blood or cell suspension from lymph
nodes. It is true that in these negative experiments there was only a relatively small number
of tests.
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H. S. Lawrence (3) succeeded in passive local transfer of delayed 48-hour type sensitivity
to tuberculin and to streptokinase in man. He utilized suspensions of viable white blood
cells from sensitive donors and injected these intracutaneously into nonsensitive recipients.
Passive sensitization was then demonstrated in the injected site; when relatively large
quantities of white cells had been used there was also generalized sensitization of the skin.
Baer and Sulzberger (4) in a previous report described attempts at passive transfer of
allergic eczematous contact-type sensitivity in man by the technic of H. S. Lawrence (3).
Suspensions of viable white cells from the blood of 27 sensitive donor subjects were injected
intracutaneously into the skin of 27 recipient subj ects not sensitive to the allergen under
study. Patch tests with the specific allergen after the cell transfer were negative in 21
subjects, questionable in 2, and positive in 4. However, when the four recipients with
positive patch tests were retested after 2 to 8 months the patch tests were still positive.
The conclusions from these results were that the attempts at passive transfer had un-
equivocally failed in the large majority of cases; and that the evidence at hand was in-
adequate to decide whether the sensitization in the four recipients with positive tests was
of the passively transferred type or whether it had been actively produced through sensitiza-
tion by repeated patch testing with the allergen under study. Baer and Sulzberger (4)
considered the possibility that the white cells of patients with allergic eczematous sensi-
tivity to a specific allergen may contain a factor which, when mi ected intracutaneously into
non-sensitive subjects, increases their capacity to undergo active sensitization upon ex-
posure to the particular eczematogenic agent.
In view of the non-decisive results of the previous studies by our group it was
decided to carry out further attempts at passive transfer using a different technic*
which would yield larger quantities of viable white cells in suspensions and
which would not involve potentially white cell-damaging procedures such as
repeated washings and high speed centrifugation. These most recent and pre-
viously unreported tests form the subject of the present report.
EXPERIMENTAL TECHNIC
45 ml. of blood is drawn from the cubital vein of the donor hypersensitive to some known
eczematogenous allergen. The blood is withdrawn by means of a sterile 50 ml. syringe with
a 16 gauge needle which has previously been rinsed out first with sterile distilled water and
then with sterile flanks Solution.t This blood is transferred into a sterile 50 ml. glass stop..
* We are grateful to Dr. Merrill Chase for his suggestions regarding improved technics.
f Hanks Solution:
5m8.
NaCI 8.0
KC. 0.4
MgSO4.7H20 0.1
MgCL2.6H20 0.1
Na2HPO4.2H20 0.06
KH2PO4 0.06
Glucose 1.0
CaC12 0.14
Gelatin 1.67 (6% stock)
Bring to 950 ml. with distilled water. Bubble in CO2 gas. Add NaHCO3 until final pH is
between 7.2—7.6. Bring to final volume of 1000 ml. Store in 50 ml. lots using rubber stoppers
to maintain CO2. Use 1 flask as a constant pH reference control.
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pered pyrex graduate containing 5 ml. of citratefibrinogen* in Hanks Solution,t previously
warmed to 37°C. in a water bath. The blood and anticoagulant are then mixed by gently
inverting the tubes and returned to the water bath at 37°C.
The collection of white blood cells is started before there is complete sedimentation of red
blood cells (which usually takes not more than 3hour) and before formation of a buffy coat
has taken place. While the red blood cells are settling, leaving what is largely a plasma
suspension of white blood cells, this suspension is collected at appropriate intervals by
means of a Pasteur pipette. It is transferred into 2 or more steriie conical 15 ml. centrifuge
tubes which are maintained at 37°C. in a water bath.
When all available plasma suspension of viable white cells has been collected, it is cen-
trifuged at 1800 RPM for 5 minutes and then all but 0.5 ml. of the supernatant is carefully
drawn off from each tube. The material from the several tubes is pooled after resuspension
of the white cells in the small amount of remaining plasma in each tube by means of gentle
repeated pipette aspiration.
As soon as possible afterwards the white cell suspension is injected intracutaneously into
the recipient test subjects. However, to avoid unnecessary injury to the white cells, the
white cell suspension is pipetted into the open barrel end of a 2 ml. tuberculin syringe,
after a 20 gauge needle has been attached to the other end. The plunger is then reinserted,
the suspension is freed from air bubbles and injection is performed before the white cells
have had a chance to settle.
This technic as compared with that previously used by Lawrence (3) and Baer
and Sulzberger (4) has the following advantages: 1) the yield of white blood
cells greatly exceeds that from the formerly used technic; 2) no special centrifuge
tubes are required; 3) avoidance of the several washings of the leukocytes and
high speed centrifugation and thus avoidance of unnecessary damage to the
leukocytes. Repeated microscopic examination for ameboid movements and vital
staining with trypan blue showed that leukocytes garnered by this technic were
viable for more than 4 hours. Since the time interval between collection of the
blood from the sensitive donor to the injection of the white cell suspension into
the non-sensitive recipient was only about 45 to 60 minutes we were assured of
always injecting viable leukocytes with this technic.
The actual yield in viable white cells from each 45 ml. sample of blood, was
about 0.2 ml. suspended in 1 to 2 ml. of plasma. This quantity of white cell
suspension was divided into four equal amounts and was injected into four sites
on the outer aspect of the upper arm of the recipient. The cell suspension, when
injected in this manner, caused variable degrees of infiltration, induration and
erythema at the injected site, lasting for about 48 hours.
Donor subjects: this group consisted of 66 patients who, on the basis of positive
patch test responses and clinical events, were known to have an allergic eczema-
* Citrate-fibrinogen solution: Citrate-fibrinogen anticoagulant solution contains sodium
citrate 3 gms., and fibrinogen (Armour), Fraction I, 4.7 gms. brought to 100 ml. volume in
Hanks Solution. Dissolve ingredients at 37°C. For sterility, this solution is filtered through
a Seitz filter (autoclaving would cause formation of precipitates). (This reagent will con-
tain equivalents of sodium citrate per ml. of blood as is used in the Cutler sedimentation
method and a suitable concentration of fibrinogen to accelerate the settling of RBC—thus
avoiding the mixing of various solutions before use.)
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tous contact-type sensitivity (reaction of 2 plus or stronger) to one or more
substances as follows:
pats ent8
Nickel 13
Paraphenylenediamine 10
Benzocaine 8
Bichloride of mercury 5
Turpentine 4
Paraphenylenediamine and benzocaine 4
B.esorcin 3
Nickel and benzocaine 2
Ammoniated mercury and sulfur 2
Formalin 1
Sulfur 1
Paraphenylenediamine and turpentine 1
Paraphenylenediamine and nickel 1
Paraphenylenediamine, benzocaine and butesin 1
Nickel and resorcin 1
Crude coal tar and sulfur 1
Bichloride of mercury and formalin 1
Short ragweed and pyrethrum 1
Crude coal tar 1
Crude coal tar and liq. carb. detergens 1
Pyrethrum, turpentine and short ragweed 1
Pot. bichromate and linseed oil 1
Benzocaine, pot. bichromate and butesin 1
Bichloride of mercury, turpentine, and ragweed oil 1
Recipient subjects: this group consisted of 66 subjects, many of whom at the
time of their participation in the tests were suffering from dermatoses as follows:
patients
Atopic dermatitis 35
Contact dermatitis 17
No skin disease 8
Tjrticaria 2
Dermographism 2
Vitiligo 1
Chronic discoid lupus erythematosus 1
Of the 66 recipient subjects all but 20 had been patch tested some time prior
to the present studies (usually within 6 weeks) with the allergen with which
transfer was being attempted in their respective cases and had been found not
to react. It is worth noting that of the 46 previously tested recipients 30 did not
react to any of the eczematogenic allergens tested, while 16, although they did
not react to the allergen to which transfer was being attempted, did react to one
or more other substances. This appears important because it shows that at least
these 16 subjects had the capacity to undergo eczematous sensitization.
The time intervals between intracutaneous injection of the white cell suspen-
sion and application of the patch test in the recipients, to ascertain whether a
passively aquired sensitivity had arisen, was deliberately varied. This was done
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to make as certain as possible that we would not miss that interval after which
optimal passive sensitivity would be demonstrable, if it occurred at all. The
interval was
12 hours in 4 cases
18—24 hours in 18 cases
48 hours in 35 cases
72 hours or more in 9 cases.
The time interval between application and reading of the patch tests was
usually 48 hours. In a few cases readings were carried out also at 24 and 72
hours. In each subject one patch test was applied over one of the sites of in-
TABLE I
Experimental data in the positive reactors
DONOR ACTIVELY SENSITIVE To BICNLORIDE RESORCIN
Recipient's reaction to patch test with
donor's allergen before cell transfer
Negative Negative Not done but test ap-
plied at time of cell
transfer was negative
48 hours later (see
text)
Interval between cell transfer and
patch test done before cell transfer
14 days 21 days —
Interval between cell transfer and
patch test done after cell transfer
14 days 2 days 2 days
Interval between patch test applica-
tion and reading and result
2 days
2 plus
2 days
2 plus
2 days
3 plus
Interval between cell transfer and
latest patch test done and result
5 months
4 plus
45 days
2 plus
3 months
3 plus
jection of white blood cells and another in an unprepared site on the back. In
this manner it was possible to ascertain whether local or generalized sensitization
had occurred.
The patch tests were repeated in many subjects at intervals of 4, 12, 30 and
90 or more days after the injection of the white cells. This was done to be able
to observe variations in the degree of sensitivity which might develop as a con-
sequence of the cell transfer.
In the early part of these experiments various types of control tests were
carried out, including injection of the donor's plasma without cells and of
Hanks Solution without cells, as well as application of a patch test to a site which
had been injected with a suspension of white cells from a donor who was not
sensitive to the allergen under study.
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RESULTS
The patch test reaction was positive at the cell injected site and control site
in 3 recipient subjects (in 1 to p-phenylenediamine, in 1 to resorcin and in 1 to
bichloride of mercury). The details of the tests in these 3 "positive" reactors
are shown in Table I.
The patch test reaction at the cell injected site and control site was question-
ably positive in one subject at 4 days after injection of white cells from a donor
sensitive to nickel sulfate, with negative reactions on repetition of the test 6 and
20 days later.
The patch test reaction at the cell injected site and control site in the recipient
subjects was unequivocally negative in 62. However, 4 of these subsequently
developed what appeared to be an active sensitization to the allergen under
study (in 3 subjects to p-phenylenediamine and in 1 to turpentine). This was
indicated by a spontaneous fiareup at the patch test sites in 2 subjects and by
positive reaction upon repatch testing in 2 subjects 9, 18, 20 and 49 days re-
spectively after the cell transfer.
COMMENT
Our previous report (4) dealt with attempts to passively transfer eczematous
allergic sensitivity in man by means of suspensions of viable white cells according
to the technic of H. S. Lawrence (3). In these earlier studies we came to the
conclusion that there was no definite decision possible as to whether we had
achieved passive transfer or whether we had produced active sensitization in the
positive reactors. The tests reported above, using what we believed to be a
more suitable technic, still do not permit a final decision.
However, taking the results of our previous and our present series together,
it appears to us more probable that the recipient subjects with persistently positive
reactions in both series of experiments became actively rather than passively sen-
sitized.
The evidence from our previous and our present series of tests in favor of
active sensitization is as follows:
1. In all "positive" recipients who were available for retesting 2 to 8 months
after the cell transfer the patch tests still were positive. While it appears possible
that a passively acquired eczematous sensitivity might persist over a period of
many weeks to months, one would assume that such an event is rather unlikely,
particularly since on retesting no decrease in the intensity of any of the reactions
was observed.
2. The "positive" recipients had been patch tested with eczematogenic sub-
stances which are known to have a rather high sensitizing index e.g. with p-
phenylenediamine, turpentine, mercury and nickel. The one possible exception
is the subject who became sensitive to resorcin. No positive reactions were pro-
duced with allergenic substances with a relatively low sensitizing index, e.g.,
coal tar, precipitated sulfur and ragweed oleoresin, despite the fact that the
donor patients had very strong sensitivities to these allergens. Moreover, not
one of the 20 subjects who had never been patch tested previously was among
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those who developed positive reactions after the cell transfer. However, it is
realized that the series is not large enough to permit any statistically reliable
conclusions on this point.
3. The recipients with "potive" tests, with the exception of the resorcin
sensitive recipient, had had previous patch test exposure to the allergen under
study. This means, of course, that they might have undergone active sensitiza-
tion due to this exposure. However, there is no entirely satisfactory explanation
for the events in the subject who devdoped a positive reaction to resorcin for he
had had a negative reaction to a patch test with resorcin which had been applied
at the time of cell injection. This negative test was read 48 hours later at the
precise time when the next patch test was applied. This newly applied test
turned out to be positive when read 48 hours subsequently. The only explanation
we have to offer for this is that the first patch test, applied at the time of the cell
injection, had produced an active sensitization which became evident 96 hours
later.
4. Apart from the positive reactors in whom no definite decision can be made as
to whether their sensitivity was acquired actively or passively, there were 4 sub-
jects in our present series and 1 in our previous series in whom a sensitivity was
obviously actively acquired (as evidenced by fiareups at patch test sites or
positive patch test reactions many days to weeks after the white cell injection
had been given). In 4 of these the allergen was p-phenylenediamine and in 1
turpentine.
If one assumes that all the sensitizations seen in our two series of experiments
were of the active type, one is faced with the fact that 13% i.e. 12 (5 in the first
and 7 in the second series) out of 93 subjects tested (27 in the first and 66 in the
second series) became actively sensitized. An incidence of 13% sensitizations
from patch testing is a rather unusual occurrence; for if it were the usual effect
of patch testing, this form of skin testing could not have become the routine
procedure which has made it so invaluable a tool in the modern practice of
dermatology.
This brings up again the theoretical possibility, mentioned in our previous pub-
lication (4), that the white cell suspensions of patients with allergic eczematous
sensitivity may contain a hitherto unsuspected and unknown factor which, when
injected into the skin of a previously nonsensitive recipient, facilitates or stimu-
lates the recipient's becoming actively sensitized to the allergen to which the donor
of the cells has an eczematous sensitivity. There is, at this time, no adequate in-
formation available whether such a factor, if it exists, facilitates or stimulates
active sensitization on a specific or a non-specific basis. However, the fact
that none of the 12 subjects, to our knowledge, developed any other eczematous
allergic sensitizations since our experiments were done, speaks somewhat in favor
of a specific action.
In consonance with this possibility is the work of Chase (5) who observed the
development of antibodies to picryl chloride, o-chlorobenzoyl chloride, and sheep
erythrocytes and anaphylactic hypersensitivity to o-chlorobenzoyl chloride in
animals who had been injected with cells taken from lymph nodes of animals who
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had been sensitized or immunized with these materi&s; and the work of Harris,
Harris and Farber (6, 7) who detected formation of agglutinins against dy-
sentery bacilli in rabbits following transfer of cells irom lymph nodes of rabbits
who had been immunized with dysentery bacilli.
While in interpreting the animal experiments just cited (5, 6, 7) there is room
for discussion as to whether the passively transferred cells contained traces of
antigenic material which, although extremely small, may have been sufficiently
large to engender active sensitization in the receptor animals, such a possibility
appears practically excluded in the human beings who became actively sen-
sitized in our tests. For our donor subjects had not been injected with the antigen
as had been done in the animal experiments; rather they had had only 2 or 3
patch test exposures to the allergenic substances.
The fascinating possibility of the existence of a factor in the white blood cells
of sensitized human beings (4) and in the lymph node cells of sensitized or im-
munized animals (5, 6, 7) which engenders or facilitates active sensitization in
human beings and active antibody formation in animals injected with these cells,
finds further support in the experiments reported here.
SUMMARY
Passive transfer of allergic eczematous contact-type sensitivity was at-
tempted by injecting plasma suspensions of viable white cells from 66 sensitive
human donor subjects into 66 previously non-sensitive human recipients.
In 3 of the recipients positive tests (1 each to p-phenylenediamine, mercury
and resorcin) were seen. The sensitivity which had developed in these 3 recipi-
ents was persistent, and demonstrated by repeated positive patch test reactions
of undiminished intensity many weeks to months after the cell transfer.
In 1 additional recipient the test was questionably positive.
In the remaining 62 subjects the patch tests after cell transfer were negative,
but in 4 of these, evidence of active sensitization developed later on.
While the occurrence of a passive transfer of eczematous allergic sensitivity
in 3 of the recipient subjects cannot be ruled out, the evidence obtained in the
experiments reported here and in a previous series of tests by Baer and Sulz-
berger speaks more in favor of active sensitization. If this assumption should be
correct the results indicate an incidence of 13% active sensitizations among the
93 subjects included in the two series of experiments.
As in the first report, the possibility is again considered that the white cell
suspensions of patients with allergic eczematous sensitivities may contain a
factor which, when injected intracutaneously into previously non-sensitive sub-
jects, facilitates or stimulates the recipients' specific active sensitization to the
allergen to which the donors of the cells are sensitive.
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